Matricryptins and matrikines: biologically active fragments of the extracellular matrix - PubMed (original) (raw)

Review

Matricryptins and matrikines: biologically active fragments of the extracellular matrix

Sylvie Ricard-Blum et al. Exp Dermatol. 2014 Jul.

Abstract

Numerous extracellular proteins and glycosaminoglycans (GAGs) undergo limited enzymatic cleavage resulting in the release of fragments exerting biological activities, which are usually different from those of the full-length molecules. In this review, we define matrikines and matricryptins, which are bioactive fragments released from the extracellular matrix proteins, proteoglycans and GAGs and report their major biological activities. These fragments regulate a number of physiopathological processes including angiogenesis, cancer, fibrosis, inflammation, neurodegenerative diseases and wound healing. The challenges to translate these fragments from molecules biologically active in vitro and in experimental models to potential drugs are discussed in the last part of the review.

Keywords: bioactive fragments; endostatin; extracellular matrix; matricryptins; matrikines.

© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources